Pentobarbital capabilities throughout the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This motion potentiates GABA effects, causing CNS despair and inhibiting glutamate, additional resulting in an additive effect on CNS depression. Although the not enough an antidote has led to lessened initially-line usage from the drug,